News Focus
News Focus
icon url

HGiLS

11/18/24 6:47 PM

#415286 RE: NASDAQ2020 #415285

Only if the dea or fda open their mouth instead of increasing the quota for elite.
icon url

kennyt 335

11/18/24 6:58 PM

#415287 RE: NASDAQ2020 #415285

Looking good NASDAQ2020!!! .89 and lm a club member ELTP💪🤞 🇺🇸tommorrow
icon url

Trend-Setter

11/18/24 7:20 PM

#415289 RE: NASDAQ2020 #415285

GREAT NEWS today!
Trying to connect the dots.
I posted this before and just can't get rid in my thoughts.


Trend-Setter
Re: HGilS post# 412711

Thursday, October 24, 2024 7:07:36 PM

Post#
412712
of 415286
Now you just made me speculate about a probability that Elite's new API supplier is the same one Dexcel is using. Remember the long awaited Adderall approval process in Israel (almost 3 years)? Is it possible they used a different API supplier on the Adderall which is the new API supplier being referred to for Vyvanse? Any thoughts from our chemists here?



Now if my speculation turns out to be exactly what had happened, then we expect that Elite and Dexcel will execute another marketing contract agreement for generic Vyvanse or an amendment to the existing contract but only this time without further delay on approval with the Israeli Ministry of Health. Any thoughts Winechemists and others in the drug mfg. industry?